Home > PS Ratio > NEULAND LABORATORIES

NEULAND LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of NEULAND LABORATORIES is 11.50.

Share Price ₹13,731.3Jan 30,2025
Market Cap ₹17,576.1 Cr
Sales-TTM₹1,528.3 CrTTM-Consolidated Results
Price/Sales11.50xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NEULAND LABORATORIES is calculated as :

Current Market Cap [ ₹17,576.1 Cr] as on Jan 30,2025

(/) Sales [ ₹1,528.3 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 11.50x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '11.50 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !

The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES


PS Ratio Performance Analysis for NEULAND LABORATORIES

- NEULAND LABORATORIES 's latest p/e ratio is 11.50x.

- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.37x.

- NEULAND LABORATORIES 's operated at median p/e ratio of 1.94x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2024 at 5.17x.

- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.48x.


How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NEULAND LABORATORIES 1,528.311.5017,576.1
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.32418,744.0
CIPLA LTD26,981.24.36117,762.0
DR REDDYS LABORATORIES LTD31,229.33.1999,705.3
ZYDUS LIFESCIENCES LTD21,483.54.4795,929.3
DIVIS LABORATORIES LTD8,614.017.67152,209.0
MANKIND PHARMA LTD11,641.08.82102,663.0
TORRENT PHARMACEUTICALS LTD11,302.010.05113,621.0
LUPIN LTD21,431.34.4094,191.9
AUROBINDO PHARMA LTD30,295.02.2768,671.1
ABBOTT INDIA LTD6,066.19.1455,449.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.27x
Max industry PS 17.67x
Median industry PS 8.32x
Average industry PS 7.65x



You may also like the below Video Courses